References
https://www.gov.uk/guidance/exceptional-good-distribution-practice-gdp-flexibilities-for-medicines-during-the-coronavirus-covid-19-outbreak
Claire has a detailed knowledge of GMP and actively promotes a positive QA culture within the workplace and with client accounts.
Latest posts by Claire Crewe (see all)
- MHRA Compliance Monitor (CM) programme - April 8, 2022
- 5 considerations for managing GDP risk and process changes during COVID-19 - May 22, 2020